J Vet Sci.  2011 Sep;12(3):227-233. 10.4142/jvs.2011.12.3.227.

Risk factors associated with bacteriological cure, new infection, and incidence of clinical mastitis after dry cow therapy with three different antibiotics

• Gundelach
• Kalscheuer E
• Hamann H
• Hoedemaker M

• KMID: 1067394
• DOI: http://doi.org/10.4142/jvs.2011.12.3.227

Abstract

Factors affecting bacteriological cure rates (BCR) and new intramammary infections (IMI) during the dry period as well as clinical mastitis (CM) during early lactation were investigated in 414 German Holstein dairy cows receiving dry cow therapy. Cows were treated with either benethamine benzylpenicillin (300,000 IU), penethamate hydriodide (100,000 IU), and framycetin sulphate (100 mg, n = 136), or cefquinome (150 mg, n = 135), or benzathine cloxacillin (1,280 mg, n = 143). Overall BCR, IMI, and CM at parturition were 86.4%, 20.7%, and 4.3%, respectively. The three antibiotic treatments differed only in BCR, with cloxacillin yielding better results than the others. Udder quarters from cows with > 4 lactations had a higher risk of IMI and CM at calving. Chronic changes in udder tissues were linked to a lower BCR and were associated with a higher risk of CM during early lactation. The risk of CM at calving was higher in udder quarters with unspecific or subclinical mastitis before drying off. In conclusion, with antibiotic dry cow therapy, age and health status of the udder appear to be major determinants of IMI and CM during the dry period and early lactation, while BCR was associated with the antibiotic type and udder tissue status.

Keyword

dry cow treatment; risk factors; treatment success

MeSH Terms

Animals
Anti-Bacterial Agents/administration & dosage/*therapeutic use
Bacterial Infections/drug therapy/epidemiology/prevention & control/*veterinary
Cattle
Cephalosporins/administration & dosage/therapeutic use
Female
Framycetin/administration & dosage/therapeutic use
Germany/epidemiology
Incidence
Lactation
Mammary Glands, Animal/*microbiology/physiology
Mastitis, Bovine/drug therapy/*epidemiology/prevention & control
Penicillins/administration & dosage/therapeutic use
Risk Factors

Reference

1. Adkinson RW, Ingawa KH, Blouin DC, Nickerson SC. Distribution of clinical mastitis among quarters of the bovine udder. J Dairy Sci. 1993. 76:3453–3459.

2. Bansal BK, Hamann J, Grabowskit NT, Singh KB. Variation in the composition of selected milk fraction samples from healthy and mastitic quarters, and its significance for mastitis diagnosis. J Dairy Res. 2005. 72:144–152.

3. Barkema HW, Schukken YH, Lam TJGM, Galligan DT, Beiboer ML, Brand A. Estimation of interdependence among quarters of the bovine udder with subclinical mastitis and implications for analysis. J Dairy Sci. 1997. 80:1592–1599.

4. Barkema HW, Schukken YH, Zadoks RN. Invited review: the role of cow, pathogen, and treatment regimen in the therapeutic success of bovine staphylococcus aureus mastitis. J Dairy Sci. 2006. 89:1877–1895.

5. Bradley AJ, Green MJ. Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations. J Dairy Sci. 2009. 92:1941–1953.

6. Bradley AJ, Breen JE, Green MJ. Lam TJGM, editor. An investigation of three approaches to dry cow therapy to prevent intramammary infection in the dry period and clinical mastitis in early lactation. Mastitis Control. From Science to Practice. 2008. Wageningen: Wageningen Academic;317.

7. Browning JW, Mein GA, Brightling P, Nicholls TJ, Barton M. Strategies for mastitis control: dry cow therapy and culling. Aust Vet J. 1994. 71:179–181.

8. Dingwell RT, Duffield TF, Leslie KE, Keefe GP, DesCoteaux L, Kelton DF, Lissemore KD, Schukken YH, Dick P, Bagg R. The efficacy of intramammary tilmicosin at drying-off, and other risk factors for the prevention of new intramammary infections during the dry period. J Dairy Sci. 2002. 85:3250–3259.

9. Dingwell RT, Kelton DF, Leslie KE. Management of the dry cow in control of peripartum disease and mastitis. Vet Clin North Am Food Anim Pract. 2003. 19:235–265.

10. Dingwell RT, Leslie KE, Schukken YH, Sargeant JM, Timms LL, Duffield TF, Keefe GP, Kelton DF, Lissemore KD, Conklin J. Association of cow and quarter-level factors at drying-off with new intramammary infections during the dry period. Prev Vet Med. 2004. 63:75–89.

11. Edmonson AJ, Lean IJ, Weaver LD, Farver T, Webster G. A body condition scoring chart for Holstein dairy cows. J Dairy Sci. 1989. 72:68–78.

12. Ehringer AM, Allan MJ, Hartmann M, Zschiesche E, Thomas E. Pharmacokinetic aspects of a new dry cow therapy. Cattle Pract. 2005. 13:227–230.

13. Godden S, Rapnicki P, Stewart S, Fetrow J, Johnson A, Bey R, Farnsworth R. Effectiveness of an internal teat seal in the prevention of new intramammary infections during the dry and early-lactation periods in dairy cows when used with a dry cow intramammary antibiotic. J Dairy Sci. 2003. 86:3899–3911.

14. Green MJ, Bradley AJ, Medley GF, Browne WJ. Cow, farm, and management factors during the dry period that determine the rate of clinical mastitis after calving. J Dairy Sci. 2007. 90:3764–3776.

15. Green MJ, Bradley AJ, Medley GF, Browne WJ. Cow, farm, and herd management factors in the dry period associated with raised somatic cell counts in early lactation. J Dairy Sci. 2008. 91:1403–1415.

16. Hamann J, Funke U. Dry cow treatment - actual aspects. Prakt Tierarzt. 1999. 80:1012–1017.

17. Halasa T, Nielen M, Whist AC, Østerås O. Meta-analysis of dry cow management for dairy cattle. Part 2. Cure of existing intramammary infections. J Dairy Sci. 2009. 92:3150–3157.

18. Halasa T, Østerås O, Hogeveen H, van Werven T, Nielen M. Meta-analysis of dry cow management for dairy cattle. Part 1. Protection against new intramammary infections. J Dairy Sci. 2009. 92:3134–3149.

19. National Mastitis Council. Laboratory Handbook on Bovine Mastitis. 1999. Revised ed. Madison: National Mastitis Council;1–222.

20. Natzke RP, Everett RW, Bray DR. Effect of drying off practices on mastitis infection. J Dairy Sci. 1975. 58:1828–1835.

21. Neijenhuis F, Barkema HW, Hogeveen H, Noordhuzen JPTM. Classification and longitudinal examination of callused test ends in dairy cows. J Dairy Sci. 2000. 83:2795–2804.

22. Oliver SP, Mitchell BA. Susceptibility of bovine mammary gland to infections during the dry period. J Dairy Sci. 1983. 66:1162–1166.

23. Rosenberger G. Clinical Examination of Cattle. 1979. Berlin and Hamburg: Verlag Paul Parey;350–373.

24. Steel RGD, Torrie JH. Principles and Procedures of Statistics: Biometrical Approach. 1980. 2nd ed. New York: McGraw-Hill Book.

25. Traeder W, Irion T. Economic effects of subclinical mastitis and the treatment at drying off with Orbenin Extra. Tierarztl Umsch. 1996. 51:362–368.

26. Valde JP, Lystad ML, Simensen E, Østerås O. Comparison of feeding management and body condition of dairy cows in herds with low and high mastitis rates. J Dairy Sci. 2007. 90:4317–4324.

27. Wolfinger R, O'Connell M. Generalized linear mixed models: a pseudo-likelihood approach. J Stat Comput Simul. 1993. 48:233–243.